Pharmacokinetic and pharmacodynamic characteristics of beta-blockers: when differences may matter.
Metra
Marco
M
Dei Cas
Livio
L
Cleland
John G F
JG
D000319:Adrenergic beta-Antagonists / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002227:Carbazoles / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000077261:Carvedilol; D003692:Delayed-Action Preparations; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008790:Metoprolol / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011412:Propanolamines / Q000493:pharmacokinetics* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D003692:Delayed-Action Preparations; D011412:Propanolamines; D000077261:Carvedilol; D008790:Metoprolol